Orbactiv
Payments companies reported to CMS as associated with Orbactiv. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Orbactiv, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Orbactiv
These are the largest totals companies reported as associated with Orbactiv. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Wikler | San Diego, CA | Infectious Disease | $98,361.50 |
| Andrew Dold | Dacula, GA | Infectious Disease | $5,632.11 |
| Allen Raphael | Smyrna, GA | Podiatrist | $3,571.30 |
| Martin Krsak | Denver, CO | Infectious Disease | $3,237.00 |
| John Bradley | San Diego, CA | Pediatric Infectious Diseases | $3,000.00 |
| Whitney Stevens | Chicago, IL | Allergy & Immunology | $2,800.00 |
| Daniel Benjamin Jr | Durham, NC | Pediatric Infectious Diseases | $2,450.00 |
| Melanie Dispenza | Baltimore, MD | Allergy & Immunology (Internal Medicine) | $1,500.00 |
| Natalie Neu | New York, NY | Pediatric Infectious Diseases | $1,200.00 |
| Linda White | Smithfield, NC | Family | $816.33 |
Prescribed Orbactiv?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.